CVS director Mike Mahoney, whose day job is CEO of Boston Scientific, bought 30,000 shares of the healthcare company.

A CVS spokesperson said the Emory collaboration is the first time MinuteClinic has expanded into primary care services in ...

A reescalating battle between pharmaceutical companies and pharmacy benefit managers is brewing in Washington, D.C., as ...

Retail pharmacy chain CVS Health (CVS) is scheduled to announce its results for the fourth quarter of 2024 before the market ...

CVS Health steered through rising costs in its insurance division to handily beat profit expectations on Wall Street. The ...

Despite a recent 45% rally, I maintain a 'Sell' view on CVS due to its underwhelming execution record and rising leverage ...

Our drive to greater drug pricing transparency through innovation has never been more needed,” Ed DeVaney says.

Ed DeVaney’s promotion is the latest leadership shakeup at CVS Health as the company works on a multi-year turnaround plan.

CVS Health Corp (NYSE:CVS) reported fourth-quarter sales of $97.71 billion, beating the consensus of $97.19 billion. Total ...

CVS Health (CVS) stock soared about 15% yesterday after posting upbeat fourth-quarter results, with revenues and earnings ...

We highlight five stocks in SPY that are leading midway through Q1. CVS Health Corporation's ( NYSE:CVS ) stock was strong despite it releasing a soft earnings report last week. However ...